Commercialization in new fields and accelerated launches of new products
First written in FY2017-Q1. 9 of 14 entries say "Advanced", first in FY2020. Latest entry: 2026-10-30.
41 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In the semiconductor manufacturing equipment business, we developed the direct-write lithography system “DW-3100,” achieving world-class high resolution for the advanced semiconductor packaging market, where demand is expanding against the backdrop of the rapid evolution of AI semiconductors in recent years.」
The company developed the “DW-3100” system for advanced semiconductor packaging as a new business area and described specific progress toward commercializing the product. - FY2026-H1AdvancedAnnual report
「The Other segment comprises business segments not included in the reportable segments and includes the development, manufacture and sale of products in new business fields related to advanced semiconductor packaging, life sciences and hydrogen, as well as the planning and production of documents and the development and sale of software.」
Advanced semiconductor packaging was explicitly identified in the description of new business fields and listed, alongside life sciences and hydrogen-related businesses, as an area covering product development, manufacturing and sales. - FY2024RaisedAnnual report
「The contents of the next medium-term management plan Value Up Further 2026 (fiscal years ending March 2025 through March 2027) are as follows. ・Innovation management: Launch of new technologies and new products, and establishment of a new business on a scale of ¥10,000 million」
The new medium-term plan sets out the launch of new technologies and new products, as well as the establishment of a new business on a scale of ¥10,000 million, giving greater specificity to the commercialization targets. - FY2023AdvancedAnnual report
「c. Continuing to pursue the creation of new businesses (life sciences, energy, AI) AFIテクノロジー was made a subsidiary to strengthen the life sciences business Establishment of the Hydrogen-Related Business Office was approved to strengthen the hydrogen energy business (established on 1 April 2023) Additional investment was made in Laboro.AI to advance the overall manufacturing process through the use of AI technology」
The company identified life sciences, energy and AI as new business fields and described specific progress through the acquisition of AFIテクノロジー as a subsidiary, the establishment of the Hydrogen-Related Business Office and additional investment in Laboro.AI. - FY2021-Q1AdvancedAnnual report
「● Continuing to pursue the creation of new businesses (life sciences, inspection and measurement, energy, AI)」
The company identified life sciences, inspection and measurement, energy and AI as the target new fields and stated that it would continue pursuing their commercialization in the new medium-term plan. - FY2020AdvancedAnnual report
「Outside the segments listed above, we engaged in basic research and research and development in new business fields. In the life sciences field, we jointly developed with universities a cannula for perfusion transplantation and a heat-shielding bag designed to suppress increases in organ temperature during transplantation.」
In the new business fields, the document describes specific product development achievements through joint development with universities in the life sciences field. - FY2017SoftenedAnnual report
「Against the plan's targets of ① completing structural reform of the earnings model and establishing a highly profitable business structure, with an operating margin of 10% or higher in the final year, ② commercializing new fields, and ③ strengthening the financial position, with an equity ratio of 50% or higher at the end of the final year, we achieved a certain level of results despite delays in commercializing new fields.」
The company explicitly stated that commercialization in new fields was behind the targets of Challenge2016. Meanwhile, in life sciences, inspection and measurement and other areas, it has been progressing with deliveries of evaluation equipment and aims to move from the equipment evaluation phase to the phase of increasing sales. - FY2017-Q3RestatedAnnual report
「In our efforts to commercialize new fields, we advanced product development and accelerated the market launches of new products. Under our open innovation strategy, we also entered into sales agreements and conducted joint research with other companies, as well as acquiring companies.」
We continue to commercialize new fields, develop products and accelerate the market launches of new products. - FY2017-Q2RestatedAnnual report
「In our efforts to commercialize new fields, we advanced product development and accelerated the market launches of new products. Under our open innovation strategy, we also entered into sales agreements and conducted joint research with other companies, as well as acquiring companies.」
We continue to commercialize new fields, develop products and accelerate the market launches of new products. - FY2017-Q1First statedAnnual report
「In our efforts to commercialize new fields, we advanced product development and accelerated the market launches of new products. Under our open innovation strategy, we also entered into sales agreements and conducted joint research with other companies, as well as acquiring companies.」
The document describes advancing product development and the market launches of new products as means of commercializing new fields.